| Revenue Disaggregation |
| Note 10. |
Revenue Disaggregation |
The Company generates product revenues from products
which are sold into the human and animal healthcare markets.
The following table presents the Company’s disaggregated revenues
by source:
| Schedule of disaggregated revenues by revenue source |
|
|
|
|
|
|
|
|
| |
|
Three Months Ended |
|
Nine Months Ended |
| |
|
December 31, |
|
December 31, |
| |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| Human Care |
|
$ |
3,863,000 |
|
|
$ |
3,188,000 |
|
|
$ |
12,534,000 |
|
|
$ |
9,358,000 |
|
| Animal Care |
|
|
486,000 |
|
|
|
376,000 |
|
|
|
1,434,000 |
|
|
|
1,176,000 |
|
| |
|
$ |
4,349,000 |
|
|
$ |
3,564,000 |
|
|
$ |
13,968,000 |
|
|
$ |
10,534,000 |
|
The following table shows the Company’s revenues by geographic
region:
| Schedule of revenues by geographic region |
|
|
|
|
|
|
|
|
| |
|
Three Months Ended |
|
Nine Months Ended |
| |
|
December 31, |
|
December 31, |
| |
|
2025 |
|
2024 |
|
2025 |
|
2024 |
| United States |
|
$ |
1,218,000 |
|
|
$ |
614,000 |
|
|
$ |
3,672,000 |
|
|
$ |
1,930,000 |
|
| Europe |
|
|
1,560,000 |
|
|
|
1,257,000 |
|
|
|
5,179,000 |
|
|
|
3,943,000 |
|
| Asia |
|
|
800,000 |
|
|
|
579,000 |
|
|
|
2,519,000 |
|
|
|
1,832,000 |
|
| Latin America |
|
|
518,000 |
|
|
|
829,000 |
|
|
|
1,614,000 |
|
|
|
2,174,000 |
|
| Rest of the World |
|
|
253,000 |
|
|
|
285,000 |
|
|
|
984,000 |
|
|
|
655,000 |
|
| Total |
|
$ |
4,349,000 |
|
|
$ |
3,564,000 |
|
|
$ |
13,968,000 |
|
|
$ |
10,534,000 |
|
|